New Actions of Melatonin on Tumor Metabolism and Growth

Melatonin is an important inhibitor of cancer growth promotion while the essential polyunsaturated fatty acid, linoleic acid is an important promoter of cancer progression. Following its rapid uptake by tumor tissue, linoleic acid is oxidized via a lipoxygenase to the growth-signaling molecule, 13-hydroxyoctadecadienoic acid (13-HODE) which stimulates epidermal growth factor (EGF)-dependent mitogenesis. The uptake of plasma linoleic acid and its metabolism to 13-HODE by rat hepatoma 7288CTC, which expresses both fatty acid transport protein and melatonin receptors, is inhibited by melatonin in a circadian-dependent manner. This inhibitory effect of melatonin is reversible with either pertussis toxin, forskolin or cAMP. While melatonin inhibits tumor linoleic acid uptake, metabolism and growth, pinealectomy or constant light exposure stimulates these processes. Thus, melatonin and linoleic acid represent two important environmental signals that interact in a unique manner to regulate tumor progression and ultimately the host-cancer balance.

[1]  D. Blask,et al.  13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. , 1999, Cancer research.

[2]  D. Blask,et al.  Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats. , 1997, Laboratory animal science.

[3]  W. Glasgow,et al.  The Linoleic Acid Metabolite, (13S)-Hydroperoxyoctadecadienoic Acid, Augments the Epidermal Growth Factor Receptor Signaling Pathway by Attenuation of Receptor Dephosphorylation , 1997, The Journal of Biological Chemistry.

[4]  D. Blask,et al.  Melatonin Suppression of Tumor Growth in vivo: A Novel Mechanism Involving Inhibition of Fatty Acid Uptake and Metabolism , 1997 .

[5]  D. Blask,et al.  Dietary linoleic acid intake controls the arterial blood plasma concentration and the rates of growth and linoleic acid uptake and metabolism in hepatoma 7288CTC in Buffalo rats. , 1997, The Journal of nutrition.

[6]  D. Blask,et al.  MELATONIN REGULATION OF TUMOR GROWTH AND THE ROLE OF FATTY ACID UPTAKE ANDMETABOLISM , 1997 .

[7]  M. Dahl.  Melatonin madness: Reppert SM, Weaver DR. Cell 1995;83:1059–1062 , 1996 .

[8]  D. Stump,et al.  Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein , 1995 .

[9]  D. Klurfeld.  Fat effects in experimental tumorigenesis , 1995 .

[10]  H. Lodish,et al.  Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein , 1994, Cell.

[11]  S. Cos,et al.  Melatonin modulates growth factor activity in MCF‐7 human breast cancer cells , 1994, Journal of pineal research.

[12]  L. Sauer,et al.  The effect of omega-6 and omega-3 fatty acids on 3H-thymidine incorporation in hepatoma 7288CTC perfused in situ. , 1992, British Journal of Cancer.

[13]  L. Sauer,et al.  Uptake of plasma lipids by tissue-isolated hepatomas 7288CTC and 7777 in vivo. , 1992, British journal of cancer.

[14]  Y. Cho‐Chung.  Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. , 1990, Cancer research.

[15]  S. Hill,et al.  Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. , 1988, Cancer research.

[16]  L. Sauer,et al.  Identification of linoleic and arachidonic acids as the factors in hyperlipemic blood that increase [3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. , 1988, Cancer research.

[17]  Dauchy Rt,et al.  Preparation of "tissue-isolated" rat tumors for perfusion: a new surgical technique that preserves continuous blood flow. , 1986 .

[18]  L. Sauer,et al.  Preparation of "tissue-isolated" rat tumors for perfusion: a new surgical technique that preserves continuous blood flow. , 1986, Laboratory animal science.

[19]  F. DeRubertis,et al.  Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP. , 1976, Metabolism: clinical and experimental.